Previous / Next

[20120303. Complications of EMR/ESD (58): Bleeding (22) - aspirin (2) Stopping aspirin before ESD]

Bleeding after ESD. 2022-10-16. ÀÌÁØÇà

Á¤¸» EMR/ESDÀü ¾Æ½ºÇǸ°À» ²÷Áö ¾Ê¾Æµµ ÁÁÀ»±î¿ä? ¿©±â¿¡´Â ¸¹Àº ³í¶õÀÌ ÀÖ½À´Ï´Ù. °á±¹Àº individualizeÇÒ ¼ö ¹Û¿¡ ¾ø´Â ¹®Á¦ÀÔ´Ï´Ù. Àǻ纰, ȯÀÚº°·Î Â÷À̸¦ ÀÎÁ¤ÇÏÁö ¾Ê°í Çϳª·Î Á¤¸®ÇÏ·Á´Ï ´Ù¼Ò ¹«¸®°¡ µû¸£´Â °ÍÀÔ´Ï´Ù.

ÃÖ±Ù ±¹¸³¾Ï¼¾ÅÍ¿¡¼­ ¹ßÇ¥ÇÑ ³í¹®À» ¼Ò°³ÇÕ´Ï´Ù. °á·ÐÀº ÀÌ·¸½À´Ï´Ù. "Continuous aspirin use increases the risk of bleeding after gastric ESD. Aspirin use should be stopped in patients with a low risk for thromboembolic disease to minimize bleeding complications."

Àúµµ µ¿ÀÇÇÕ´Ï´Ù. Low risk¿¡¼­´Â ¾Æ½ºÇǸ°À» ²÷À» ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ¼¼ °¡Áö ¹®Á¦´Â ³²½À´Ï´Ù. (1) ¾îµð±îÁö°¡ low riskÀΰ¡? (2) High risk¿¡¼­´Â ¾î¶»°Ô ÇÒ °ÍÀΰ¡? (3) ¾Æ½ºÇǸ°À» ²÷´Â´Ù¸é ±× ±â°£Àº?


[Âü°í ÀÚ·á]

1) EndoTODAY ¿ÍÆĸ°

2) Ç×Ç÷¼ÒÆÇÁ¦ Antiplatelets - ³»½Ã°æ ȤÀº Á¶Á÷°Ë»ç Àü ¾Æ½ºÇǸ°, Ç×Ç÷¼ÒÆÇÁ¦¸¦ ²÷À» °ÍÀΰ¡?

3) »õ·Î¿î Ç×ÀÀ°íÁ¦ New oral anticoagulant (NOAC)

4) Ç×Ç÷¼ÒÆÇÁ¦, Ç×ÀÀ°íÁ¦ Áß´Ü Áöħ (»ï¼º¼­¿ïº´¿ø 2011)

© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà